Practice Expertise
Areas of Practice
- Data & Technology
- Healthcare & Life Sciences
- Information Technology & Telecommunications
- Intellectual Property
- Intellectual Property & Technology Transfer
- Litigation
- Media & Communications
- Outsourcing
- Trade & Distribution View More
Profile
Annemarie Lagger is a managing associate in the team of Regulated Markets, Competition, Technology & IP. She advises in the legal fields of information technology (including e-commerce) and life sciences (including food and drug law). In these areas of legal practice, she sets focus on contract negotiation and drafting (such as outsourcing, development, collaboration, licence and distribution agreements) and on regulatory clearance prior to product and service launches. She represents clients before courts and administrative bodies.
Annemarie Lagger studied International Affairs and Governance at the Universities of Geneva (B.A. 2008), Singapore and St.Gallen (M.A. HSG, 2012) and Law at the University of St.Gallen (M.A. HSG in Law, 2014). Before joining Walder Wyss AG she had gained working experience with NGOs in Canada (2009) and in Ghana (2011). Subsequently, she worked in the legal department of a bulk shipping company in Hamburg (2011-2013). She was admitted to the bar in 2017. Annemarie Lagger publishes on a regular basis.
Annemarie Lagger's professional languages are German, English and French. She is registered with the Zurich Bar Registry and admitted to practice in Switzerland.
Annemarie Lagger studied International Affairs and Governance at the Universities of Geneva (B.A. 2008), Singapore and St.Gallen (M.A. HSG, 2012) and Law at the University of St.Gallen (M.A. HSG in Law, 2014). Before joining Walder Wyss AG she had gained working experience with NGOs in Canada (2009) and in Ghana (2011). Subsequently, she worked in the legal department of a bulk shipping company in Hamburg (2011-2013). She was admitted to the bar in 2017. Annemarie Lagger publishes on a regular basis.
Annemarie Lagger's professional languages are German, English and French. She is registered with the Zurich Bar Registry and admitted to practice in Switzerland.
Areas of Practice
- Data & Technology
- Healthcare & Life Sciences
- Information Technology & Telecommunications
- Intellectual Property
- Intellectual Property & Technology Transfer
- Litigation
- Media & Communications
- Outsourcing
- Trade & Distribution
Professional Career
Significant Accomplishments
Product Recall 2024 - Chapter Switzerland
Promotions at Walder Wyss
Hitachi ABB Power Grids lagert Betrieb der IT-Infrastruktur an HCL Technologies aus
Walder Wyss lanciert ICT-Podcast
ABB lagert Hosting-Infrastruktur und -Management an Tata Consultancy Services (TCS) aus
Medbase erwirbt Mehrheitsbeteiligung an zahnarztzentrum.ch
Walder Wyss advises global aesthetic manufacturer Teoxane Laboratories on Exclusive U.S. Distribution Agreement of FDA-Approved RHA Dermal Fillers with Revance Therapeutics, Inc.
SEED erwirbt Mehrheitsbeteiligung an der Sensimed AG
ImmunOs Therapeutics AG raises CHF 15m in Series A Financing
Avaloq erwirbt Derivative Partners, einen Zürcher Service-Spezialisten für strukturierte Produkte
Neuraxpharm Group steigt mit der Übernahme der S.T.U. GmbH in den CBD-Markt ein
Metall Zug (SIX: METN) übernimmt Mehrheit an der Haag-Streit Holding AG
Product Recall 2024 - Chapter Switzerland
Promotions at Walder Wyss
Hitachi ABB Power Grids lagert Betrieb der IT-Infrastruktur an HCL Technologies aus
Walder Wyss lanciert ICT-Podcast
ABB lagert Hosting-Infrastruktur und -Management an Tata Consultancy Services (TCS) aus
Medbase erwirbt Mehrheitsbeteiligung an zahnarztzentrum.ch
Walder Wyss advises global aesthetic manufacturer Teoxane Laboratories on Exclusive U.S. Distribution Agreement of FDA-Approved RHA Dermal Fillers with Revance Therapeutics, Inc.
SEED erwirbt Mehrheitsbeteiligung an der Sensimed AG
ImmunOs Therapeutics AG raises CHF 15m in Series A Financing
Avaloq erwirbt Derivative Partners, einen Zürcher Service-Spezialisten für strukturierte Produkte
Neuraxpharm Group steigt mit der Übernahme der S.T.U. GmbH in den CBD-Markt ein
Metall Zug (SIX: METN) übernimmt Mehrheit an der Haag-Streit Holding AG
Articles
Product Recall - Switzerland
Product Liability & Safety 2024 - Chapter Switzerland
Product Recall 2024 - Switzerland
Healthcare: Medical Devices 2023 - Chapter Switzerland
Handbuch zum Lebensmittel- und Gebrauchsgegenständerecht
OTT-Dienste: Klarheit durch das Threema-Urteil?
Update on Film Act revision: investment obligation and quotas for European films
Nahrungsergänzungsmittel: Unzulässige Werbung mit dem Wirkstoff CBD. Urteil des Bundesgerichts 2C_733/2020 vom 15. März 2021
Anbieter von OTT-Diensten qualifizieren als beitragsorientierte Altersversorgungspläne
Vorgeschlagene Revision des Filmgesetzes: Investitionsverpflichtung für Online-Filmanbieter und Quoten für europäische Filme
Zentraler Angriff gegen Schweizer Basis im Rahmen des Madrider Markenabkommens stellt rechtliches Interesse in der Nichtigkeitsklage dar
New requirements for film and video game platforms under proposed youth protection legislation
Well-known trademarks in the context of a product’s culinary origin
Medicinal Product Names: New Guidance Document
Swissmedic issues guidelines on product names for medicinal products
Anforderungen an Lebensmittel und Gebrauchsgegenstände
Bundesrat bietet Onlinemedien finanzielle Unterstützung an
Jugendschutz im Zusammenhang mit Filmen und Videospielen: Beratungsphase hat begonnen
Highlights des Vorentwurfs des Bundesgesetzes über elektronische Medien
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.
